AAAAAA
Results:
1-14
|
Results: 14
Authors:
KOLVENBAG GJCM
BLACKLEDGE GRP
GOTTINGSMITH K
Citation: Gjcm. Kolvenbag et al., BICALUTAMIDE (CASODEX(R)) IN THE TREATMENT OF PROSTATE-CANCER - HISTORY OF CLINICAL DEVELOPMENT, The Prostate, 34(1), 1998, pp. 61-72
Authors:
IVERSEN P
TYRRELL CJ
KAISARY AV
ANDERSON JB
BAERT L
TAMMELA T
CHAMBERLAIN M
CARROLL K
GOTTINGSMITH K
BLACKLEDGE GRP
Citation: P. Iversen et al., CASODEX (BICALUTAMIDE) 150-MG MONOTHERAPY COMPARED WITH CASTRATION INPATIENTS WITH PREVIOUSLY UNTREATED NONMETASTATIC PROSTATE-CANCER - RESULTS FROM 2 MULTICENTER RANDOMIZED TRIALS AT A MEDIAN FOLLOW-UP OF 4 YEARS, Urology, 51(3), 1998, pp. 389-396
Authors:
BLACKLEDGE GRP
COCKSHOTT ID
FURR BJA
Citation: Grp. Blackledge et al., CASODEX(TM) (BICALUTAMIDE) - OVERVIEW OF A NEW ANTIANDROGEN DEVELOPEDFOR THE TREATMENT OF PROSTATE-CANCER, European urology, 31, 1997, pp. 30-39
Authors:
STUART NSA
WARWICK J
BLACKLEDGE GRP
SPOONER D
KEEN C
TAYLOR AR
TYRELL C
WEBSTER DJT
EARL H
Citation: Nsa. Stuart et al., A RANDOMIZED PHASE-III CROSS-OVER STUDY OF TAMOXIFEN VERSUS MEGESTROL-ACETATE IN ADVANCED AND RECURRENT BREAST-CANCER, European journal of cancer, 32A(11), 1996, pp. 1888-1892
Authors:
BLACKLEDGE GRP
Citation: Grp. Blackledge, CLINICAL-PROGRESS WITH A NEW ANTIANDROGEN, CASODEX(TM) (BICALUTAMIDE), European urology, 29, 1996, pp. 96-104
Authors:
KIRBY RS
BRINKMAN AO
FURR BJA
SOLOWAY MS
BLACKLEDGE GRP
Citation: Rs. Kirby et al., CURRENT ISSUES IN PROSTATE-CANCER - A SERIES OF DEBATES - DISCUSSION, European urology, 29, 1996, pp. 119-120
Authors:
BLACKLEDGE GRP
Citation: Grp. Blackledge, HIGH-DOSE BICALUTAMIDE MONOTHERAPY FOR THE TREATMENT OF PROSTATE-CANCER, Urology, 47(1A), 1996, pp. 44-47
Authors:
KOLVENBAG GJCM
BLACKLEDGE GRP
Citation: Gjcm. Kolvenbag et Grp. Blackledge, WORLDWIDE ACTIVITY AND SAFETY OF BICALUTAMIDE - A SUMMARY REVIEW, Urology, 47(1A), 1996, pp. 70-79
Authors:
CULLEN MH
STUART NSA
WOODROFFE C
MURPHY A
FLETCHER J
BLACKLEDGE GRP
CHILD JA
GRIEVE RJ
JONES EL
CHETIYAWARDANA AD
EARL HM
GALVIN GP
ANDREWS VE
HARPER P
LEWIS ML
MOULD JJ
MURRAY JA
NORFOLK DR
OBEID D
OFFERMAN EL
SPOONER D
STABLEFORTH PG
TUCKER J
Citation: Mh. Cullen et al., CHLVPP PABLOE AND RADIOTHERAPY IN ADVANCED HODGKINS-DISEASE/, Journal of clinical oncology, 12(4), 1994, pp. 779-787
Authors:
REDMAN CWE
WARWICK J
LUESLEY DM
VARMA R
LAWTON FG
BLACKLEDGE GRP
Citation: Cwe. Redman et al., INTERVENTION DEBULKING SURGERY IN ADVANCED EPITHELIAL OVARIAN-CANCER, British journal of obstetrics and gynaecology, 101(2), 1994, pp. 142-146
Authors:
BLACKLEDGE GRP
LOWERY K
Citation: Grp. Blackledge et K. Lowery, ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A PREDICTOR OF OUTCOME IN PROSTATE-CANCER, The Prostate, 1994, pp. 34-38
Authors:
KURTH,"DENIS L",COOPER,"BLACKLEDGE GRP
NEWLING DWW
Citation: Grp. Kurth,"denis L",cooper,"blackledge et Dww. Newling, CLINICAL DEVELOPMENTS IN PROSTATE-CANCER - PANEL DISCUSSION-2, The Prostate, 1994, pp. 39-39
Authors:
STRUTT KL
BLACKLEDGE GRP
KENNEALEY GT
Citation: Kl. Strutt et al., A PROSPECTIVE, PLACEBO-CONTROLLED STUDY OF THE ANTIANDROGEN CASODEX AS TREATMENT FOR PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA, The Journal of urology, 151(5), 1994, pp. 1355-1356
Authors:
KEHOE S
POOLE CJ
STANLEY A
EARL HM
BLACKLEDGE GRP
Citation: S. Kehoe et al., A PHASE I II TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE INTENSIFICATION OF CISPLATIN AND CYCLOPHOSPHAMIDE CHEMOTHERAPY FOR ADVANCED OVARIAN-CANCER/, British Journal of Cancer, 69(3), 1994, pp. 537-540
Risultati:
1-14
|